Jude Savarraj1, Kaushik Parsha1, Georgene Hergenroeder1, Sungho Ahn1, Tiffany R Chang1, Dong H Kim1, H Alex Choi2. 1. Department of Neurosurgery, University of Texas Health Science Center at Houston-McGovern Medical School, 6431 Fannin St, Houston, TX, 77030, USA. 2. Department of Neurosurgery, University of Texas Health Science Center at Houston-McGovern Medical School, 6431 Fannin St, Houston, TX, 77030, USA. Huimahn.A.Choi@uth.tmc.edu.
Abstract
BACKGROUND: Early brain injury (EBI) after aneurysmal subarachnoid hemorrhage (aSAH) is defined as brain injury occurring within 72 h of aneurysmal rupture. Although EBI is the most significant predictor of outcomes after aSAH, its underlying pathophysiology is not well understood. We hypothesize that EBI after aSAH is associated with an increase in peripheral inflammation measured by cytokine expression levels and changes in associations between cytokines. METHODS: aSAH patients were enrolled into a prospective observational study and were assessed for markers of EBI: global cerebral edema (GCE), subarachnoid hemorrhage early brain edema score (SEBES), and Hunt-Hess grade. Serum samples collected at ≤ 48 h of admission were analyzed using multiplex bead-based assays to determine levels of 13 pro- and anti-inflammatory cytokines. Pairwise correlation coefficients between cytokines were represented as networks. Cytokine levels and differences in correlation networks were compared between EBI groups. RESULTS: Of the 71 patients enrolled in the study, 17 (24%) subjects had GCE, 31 (44%) subjects had SEBES ≥ 3, and 21 (29%) had HH ≥ 4. IL-6 was elevated in groups with GCE, SEBES ≥ 3, and HH ≥ 4. MIP1β was independently associated with high-grade SEBES. Correlation network analysis suggests higher systematic inflammation in subjects with SEBES ≥ 3. CONCLUSIONS: EBI after SAH is associated with increased levels of specific cytokines. Peripheral levels of IL-10, IL-6, and MIP1β may be important markers of EBI. Investigating systematic correlations in addition to expression levels of individual cytokines may offer deeper insight into the underlying mechanisms related to EBI.
BACKGROUND: Early brain injury (EBI) after aneurysmal subarachnoid hemorrhage (aSAH) is defined as brain injury occurring within 72 h of aneurysmal rupture. Although EBI is the most significant predictor of outcomes after aSAH, its underlying pathophysiology is not well understood. We hypothesize that EBI after aSAH is associated with an increase in peripheral inflammation measured by cytokine expression levels and changes in associations between cytokines. METHODS: aSAH patients were enrolled into a prospective observational study and were assessed for markers of EBI: global cerebral edema (GCE), subarachnoid hemorrhage early brain edema score (SEBES), and Hunt-Hess grade. Serum samples collected at ≤ 48 h of admission were analyzed using multiplex bead-based assays to determine levels of 13 pro- and anti-inflammatory cytokines. Pairwise correlation coefficients between cytokines were represented as networks. Cytokine levels and differences in correlation networks were compared between EBI groups. RESULTS: Of the 71 patients enrolled in the study, 17 (24%) subjects had GCE, 31 (44%) subjects had SEBES ≥ 3, and 21 (29%) had HH ≥ 4. IL-6 was elevated in groups with GCE, SEBES ≥ 3, and HH ≥ 4. MIP1β was independently associated with high-grade SEBES. Correlation network analysis suggests higher systematic inflammation in subjects with SEBES ≥ 3. CONCLUSIONS: EBI after SAH is associated with increased levels of specific cytokines. Peripheral levels of IL-10, IL-6, and MIP1β may be important markers of EBI. Investigating systematic correlations in addition to expression levels of individual cytokines may offer deeper insight into the underlying mechanisms related to EBI.
Entities:
Keywords:
Early brain injury; Inflammation; Network modeling; Subarachnoid hemorrhage
Authors: J A Frontera; L Aledort; E Gordon; N Egorova; H Moyle; A Patel; J B Bederson; F Sehba Journal: J Thromb Haemost Date: 2012-04 Impact factor: 5.824
Authors: Jennifer A Frontera; Jan Claassen; J Michael Schmidt; Katja E Wartenberg; Richard Temes; E Sander Connolly; R Loch MacDonald; Stephan A Mayer Journal: Neurosurgery Date: 2006-07 Impact factor: 4.654
Authors: Svetlana M Stamatovic; Parvin Shakui; Richard F Keep; Bethany B Moore; Steven L Kunkel; Nico Van Rooijen; Anuska V Andjelkovic Journal: J Cereb Blood Flow Metab Date: 2005-05 Impact factor: 6.200
Authors: Min Ren; Qing Guo; Liang Guo; Martin Lenz; Feng Qian; Rory R Koenen; Hua Xu; Alexander B Schilling; Christian Weber; Richard D Ye; Aaron R Dinner; Wei-Jen Tang Journal: EMBO J Date: 2010-10-19 Impact factor: 11.598
Authors: Grace H Kim; Christopher P Kellner; David K Hahn; Brianna M Desantis; Muhith Musabbir; Robert M Starke; Michal Rynkowski; Ricardo J Komotar; Marc L Otten; Robert Sciacca; J Michael Schmidt; Stephan A Mayer; E Sander Connolly Journal: J Neurosurg Date: 2008-07 Impact factor: 5.115
Authors: Patricia D Hurn; Sandhya Subramanian; Susan M Parker; Michael E Afentoulis; Laurie J Kaler; Arthur A Vandenbark; Halina Offner Journal: J Cereb Blood Flow Metab Date: 2007-03-28 Impact factor: 6.200
Authors: A P Coulibaly; W T Gartman; V Swank; J A Gomes; L Ruozhuo; J DeBacker; J J Provencio Journal: Neurocrit Care Date: 2020-08 Impact factor: 3.210
Authors: Joseph R Geraghty; Melissa N Lara-Angulo; Milen Spegar; Jenna Reeh; Fernando D Testai Journal: J Stroke Cerebrovasc Dis Date: 2020-06-20 Impact factor: 2.136
Authors: Jude P J Savarraj; Georgene W Hergenroeder; Liang Zhu; Tiffany Chang; Soojin Park; Murad Megjhani; Farhaan S Vahidy; Zhongming Zhao; Ryan S Kitagawa; H Alex Choi Journal: Neurology Date: 2020-11-12 Impact factor: 9.910
Authors: Riana L Schleicher; Matthew B Bevers; Daniel B Rubin; Matthew J Koch; Søren Bache; India A Lissak; Aman B Patel; Eric S Rosenthal; Kirsten Møller; W Taylor Kimberly Journal: Stroke Date: 2021-06-25 Impact factor: 10.170
Authors: Joseph R Geraghty; Tyler J Lung; Yonatan Hirsch; Eitan A Katz; Tiffany Cheng; Neil S Saini; Dilip K Pandey; Fernando D Testai Journal: Neurosurgery Date: 2021-11-18 Impact factor: 5.315